Approved medicines in Montenegro — L — Antineoplastic and immunomodulating agents (470)
- REBIFinterferon beta-1aRxSolution for injection in pre-filled syringe, 22mcg/0.5mlMerck Serono S.p.A., Italy
- REBIFinterferon beta-1aRxSolution for injection in pre-filled syringe, 44mcg/0.5mlMerck Serono S.p.A., Italy
- REFETIBgefitinibRxFilm-coated tablet, 250mgRemedica Ltd., Cyprus
- REMABIRATabirateroneRxFilm-coated tablet, 250mgRemedica Ltd., Cyprus
- REMABIRATabirateroneRxFilm-coated tablet, 500mgRemedica Ltd., Cyprus
- REMICADEinfliximabRxPowder for concentrate for solution for infusion, 100mgJanssen Biologics B.V., Netherlands
- RESELIGOgoserelinRestrictedImplant in pre-filled syringe, 3.6mgAMW GmbH, Germany
- RESELIGOgoserelinRestrictedImplant in pre-filled syringe, 10.8mgAMW GmbH, Germany
- REVLIMIDlenalidomideRxCapsule, hard, 25mgCelgene Distribution B.V., Netherlands
- REVLIMIDlenalidomideRxCapsule, hard, 10mgCelgene Distribution B.V., Netherlands
- REVLIMIDlenalidomideRxCapsule, hard, 2.5mgCelgene Distribution B.V., Netherlands
- REVLIMIDlenalidomideRxCapsule, hard, 15mgCelgene Distribution B.V., Netherlands
- REVLIMIDlenalidomideRxCapsule, hard, 5mgCelgene Distribution B.V., Netherlands
- RINVOQupadacitinibRxProlonged-release tablet, 15mgAbbVie Logistics B.V., Netherlands
- RINVOQupadacitinibRxProlonged-release tablet, 30mgAbbVie Logistics B.V., Netherlands
- RINVOQupadacitinibRxProlonged-release tablet, 45mgAbbVie Logistics B.V., Netherlands
- RIXATHONrituximabRxConcentrate for solution for infusion, 100mg/10mlSandoz GmbH Schaftenau, Austria
- RIXATHONrituximabRxConcentrate for solution for infusion, 500mg/50mlSandoz GmbH Schaftenau, Austria
- ROACTEMRAtocilizumabRxSolution for injection in pre-filled syringe, 162mgF. Hoffmann-La Roche AG, Switzerland
- ROACTEMRA®tocilizumabRxConcentrate for solution for infusion, 80mg/4mlF.Hoffmann-La Roche Ltd., Switzerland